Analysis of the efficacy and safety of immunotherapy in advanced thymoma patients

BACKGROUND: Immunotherapy has exhibited efficacy in thymic carcinoma patients; however, there are insufficient data to confirm this efficacy in thymoma. The toxicity of immunotherapy also remains to be determined. METHODS: The efficacy and safety of immunotherapy were analyzed in 11 thymoma patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Hao, Yue, Lin, Gen, Xiang, Jing, Wang, Wenxian, Xu, Chunwei, Wang, Qian, Cai, Jing, Zhang, Yongchang, Song, Zhengbo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
BRIEF COMMUNICATION
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10028091/
https://www.ncbi.nlm.nih.gov/pubmed/36394097
http://dx.doi.org/10.1002/cam4.5357

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10028091/
https://www.ncbi.nlm.nih.gov/pubmed/36394097
http://dx.doi.org/10.1002/cam4.5357

Ejemplares similares